Background: As countries and industries continue to cope with the unparalleled challenges
presented by the novel coronavirus (COVID-19), a specific area of concern has been the uncertainty
surrounding the impact of the COVID-19 pandemic on the global and Indian supply
chains of the pharmaceutical industry. The COVID-19 crisis has demonstrated the importance of
establishing a risk management system that focuses on assessing future risks resulting from the
loss of a supply chain among countries.
Objective: This review focuses on the role of the Indian pharmaceutical industry towards the pandemic.
This review investigates the economic effect of COVID-19 across segments and what it implies
for the Indian economy.
Methods: The COVID 19 flare-up has additionally commenced the Indian pharmaceutical organizations
an opportunity to transform into a supported trade place point for gathering drugs and intermediates.
Results: An enormous pharmaceutical industry in India has consistently been a foundation of reasonable
human services, and this pattern would now be able to be required to heighten further.
Conclusion: The activities from COVID-19 are with a need to change the overall impression of Indian
pharmaceutical associations and even more altogether, reduce the dependence of the private
pharma associations on alone suppliers like China.